Physiologically, IRF7 may be activated through increased endotoxemia in the absence of apparent obesity, and it may be involved in the early induction of MCP-1 in adipose tissues. The gene discussed is CCL2; the disease is obesity due to melanocortin 4 receptor deficiency.